Skip to content

Clinical trials

Dilatation, Pathologic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dilatation, Pathologic Country / region: United States Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20083
20093
20105
20112
20122
20135
20142
20152
20165
20173
20181
20193
20205
20214
20221
20242
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting9
Unknown status8
Terminated6
Withdrawn3
No longer available1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University5
Cxlusa4
Ocuphire Pharma, Inc.4
University of California, San Diego3
Medstar Health Research Institute2
Stephen Trokel2
Topcon Medical Systems, Inc.2
University of California, San Francisco2
University of Hawaii2
University of Pittsburgh2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dilatation, Pathologic60
Keratoconus19
Corneal Diseases7
Mydriasis4
Hemorrhage3
Agnosia2
Constipation2
Deglutition Disorders2
Heart Failure2
Irritable Bowel Syndrome2

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.